Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Amantadine HCl Capsules

Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Terminated Labeling / mix-up Apace KY LLC D-1035-2017
Class II · Moderate risk

Succinylcholine Chloride

Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier

Terminated Sterility / contamination Fagron Compounding Services LLC dba Fagron Sterile Services D-0946-2017
Class II · Moderate risk

Ibuprofen Tablets

Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.

Terminated Particulate / foreign matter Time-Cap Laboratories, Inc. NDC 49483-603-50 D-1055-2017
Class II · Moderate risk

NitroGlycerin

Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Terminated Stability / shelf life Advanced Pharma Inc. NDC 15082-863-61 D-0119-2018
Class II · Moderate risk

NitroGlycerin

Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Terminated Stability / shelf life Advanced Pharma Inc. NDC 15082-863-67 D-0118-2018
Class II · Moderate risk

VenomX

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-207-01 D-0952-2017
Class II · Moderate risk

StaphWash+Plus+ Skin Protectant

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-101-01 D-0951-2017
Class II · Moderate risk

StingMed Insect bites Skin Protectant. Zinc acetate

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 04307-100-11 D-0950-2017
Class II · Moderate risk

NasalCrom (cromolyn sodium)

CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.

Terminated Microbial contamination Bausch & Lomb, Inc. D-0899-2017

Recalls by year